✦ LIBER ✦

First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study

✍ Scribed by P Papakostas; Ch Kouroussis; N Androulakis; G Samelis; G Aravantinos; K Kalbakis; E Sarra; J Souglakos; S Kakolyris; V Georgoulias

Book ID: 117657321
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 102 KB
Volume: 37
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(01)00214-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of docetaxel and cispla

A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma

✍ Daniel T.T. Chua; Jonathan S.T. Sham; Gordon K.H. Au 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase II study of docetaxel as first lin

Phase II study of docetaxel as first line chemotherapy (CT) in metastatic adenocarcinoma of the pancreas

✍ P. Preusser; N. Niederle; A. Harstrick; C. Lersch; T. Berns; W. Achterrath 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Docetaxel plus epirubicin is a highly ac

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

✍ Serafín Morales; Antonio Lorenzo; Manuel Ramos; Pedro Ballesteros; Miguel Méndez 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 692 KB

Docetaxel plus epirubicin is a highly ac

Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study

✍ Serafín Morales; Antonio Lorenzo; Manuel Ramos; Pedro Ballesteros; Miguel Méndez 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 196 KB

P-207 Docetaxel and irinotecan as first

P-207 Docetaxel and irinotecan as first line chemotherapy in patients with unresectable locally advanced or metastatic non small cell lung cancer (NSCLC): A phase II study

✍ Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 421 KB

A phase II study of paclitaxel plus carb

A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinoma

✍ Edith A. Perez; David W. Hillman; Philip J. Stella; James E. Krook; Lynn C. Hart 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 3 views

## BACKGROUND. This Phase II multicenter study evaluated the efficacy and toxicity of paclitaxel (200 mg/m 2 by 3-hour infusion) with carboplatin (area under the curve 6 mg/mL per minute) administered every 3 weeks as first-line therapy for women with metastatic breast carcinoma. ## METHODS. Eligi